Investor FAQs

Show All
What does Caladrius do?

Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease. We are developing first-in-class cell therapy products based on the finely tuned mechanisms for self-repair that exist in the human body. Our technology leverages and enables these mechanisms in the form of specific cells, using formulations and modes of delivery unique to each medical indication. To learn more about Caladrius and our CD34+ clinical development programs, please visit the About Us section.

How many employees does Caladrius Biosciences have?
As of December 31, 2020, the company has 24 full-time employees.
Where can I find Caladrius Biosciences’ latest investor presentation?
The most recent investor presentation is available under the Investors & News section.
What is Caladrius’ ticker symbol, exchange and CUSIP?
Exchange: NASDAQ
Ticker Symbol: CLBS
CUSIP: 128058203
What is Caladrius' fiscal year?
Caladrius' fiscal year ends on December 31.
Where are Caladrius Biosciences' headquarters?
110 Allen Road
Second Floor
Basking Ridge, NJ 07920 

Tel: (908) 842-0100
Who is Caladrius’ IR contact?
John D. Menditto
Vice President
Investor Relations & Corporate Communications
Phone: +1-908-842-0084
What is Caladrius’ Financial Conflict of Interest Policy?
You can view the Company’s Financial Conflict of Interest Policy by visiting the Financial Conflict of Interest Policy Statement page.
Who are Caladrius’ auditor and corporate legal counsel?
Caladrius’ auditor is Grant Thornton LLP (

Caladrius’ corporate legal counsel is Mintz Levin Cohn Ferris Glovsky and Popeo PC (
Who is Caladrius’ transfer agent?
Caladrius’ transfer agent is American Stock Transfer & Trust Company (AST) (

Telephone and email assistance
You may reach an AST representative by dialing (1-800) 937-5449 or by dialing (718) 921-8124. You can also e-mail AST at
Customer service representatives are available 8 a.m. to 8 p.m. Eastern Time, Monday through Friday.

Mail inquiries:
To contact AST via postal mail:
Caladrius Biosciences, Inc.
c/o AST
6201 15th Avenue
Brooklyn, NY 11219
Who do I contact about replacement of stock certificates?
To replace lost stock certificates, please contact Caladrius Biosciences’ transfer agent.
Who should shareholders notify of a change in address?
To change your address, please contact Caladrius Biosciences’ transfer agent.
What financial analysts cover Caladrius Biosciences?
Please refer to the Analyst Coverage section.
Can I buy Caladrius Biosciences stock directly from the company?
Caladrius does not offer a direct stock purchase plan. Shares of the company can be purchased through a brokerage company.
Does Caladrius Biosciences issue dividends on its common stock?
Caladrius Biosciences has never declared or paid cash dividends. The company intends to retain any future earnings for the operation and expansion of its business and does not anticipate paying any cash dividends in the foreseeable future.
When is Caladrius Biosciences’ Annual Meeting of Stockholders?
Specific information about this year’s Annual Shareholder Meeting can be found in this year’s proxy statement available under SEC Filings.
What should I do if I have a question that is not answered here?
Please submit your question using the form under Contact Us.